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Specimens from a patient of the 2000 Israel West Nile virus epi-
demic were analyzed by reverse transcription-polymerase
chain reaction. Products corresponding to E, NS3, and NS5
sequences were amplified from cerebellar but not from cortical
samples. Phylogenetic analyses indicated a closer relationship
of this isolate to 1996 Romanian and 1999 Russian than to
1998-99 Israeli or 1999 New York isolates.
est Nile fever is typically a mild febrile illness charac-
terized by headache, myalgias, lymphadenopathy, and a
maculopapular rash; West Nile fever occurs sporadically
throughout endemic areas of northeastern Africa and tropical
Asia (1-5). The causative agent, West Nile virus (WNV), is a
member of the genus Flavivirus (family Flaviviridae), which
is grouped together with Alfuy virus, Cacipacore virus, Kou-
tango virus, Japanese encephalitis virus, Kunjin virus, Murray
Valley encephalitis virus, St. Louis encephalitis virus, Usutu
virus, and Yaounde virus in the Japanese encephalitis virus
antigenic complex (6,7). Two different lineages (I and II) of
WNV are characterized genetically (8). Whereas lineage II
viruses are isolated in endemic areas, lineage I viruses are iso-
lated during epidemic outbreaks of WNV infection and may
cause severe encephalitis in the elderly or immunosuppressed
persons. Epidemics of West Nile fever were first reported in
the 1950s in Israel (2) and the 1970s in South Africa (9). Sites
of notable recent outbreaks include Romania (1996, 1997),
Italy (1998), Russia (1999), France (2000), United States
(1999, 2000) and Israel (2000) (5,10). Sequence analysis of
the WNV responsible for the United States outbreak in 1999
(WNV-NY1999) showed a close phylogenetic relationship to a
WNV isolated from a goose in Israel in 1998 (WNV-ISR1998)
(11,12). 
WNV is transmitted mainly by mosquito vectors, although
it has also been isolated in several tick species (3,5,13). Birds
are an important WNV reservoir. In several avian species,
virus replication generates serum titers sufficient to sustain
arthropod transmission (4,5). Birds, during seasonal
migrations, are also believed to be instrumental in the geo-
graphic spread of WNV (3-5,14). The virus is only occasion-
ally transmitted to humans or other mammals. Viremia in
mammals is low level; thus, mammals are considered to be
dead-end hosts.
The Study
From July through November 2000, a WNV epidemic
occurred in central and northern Israel. More than 430 people
were diagnosed with WNV infection; 29 of these patients had
fatal encephalitis. We report phylogenetic analysis of WNV
sequences isolated from the brain of an encephalitis patient
from the 2000 Israel epidemic. 
A 72-year-old woman with a history of recurrent meningi-
oma of the sphenoidal ridge, dementia, and depression was
hospitalized because of fever and general deterioration of 5
days’ duration. On admission, the patient was responsive only
to painful stimuli and had generalized muscle stiffness and
limb tremors. Clinical and laboratory values were consistent
with viral encephalitis; thus, the patient was initially treated
with intravenous acyclovir for presumptive herpes simplex
encephalitis. When polymerase chain reaction (PCR) analysis
of cerebrospinal fluid (CSF) showed no evidence of herpes
simplex virus infection, and WNV antibodies were detected in
serum and CSF, acyclovir was discontinued and ribavirin was
initiated at an oral dosage of 2.4 g per day. The patient’s clini-
cal status continued to deteriorate with aspiration pneumonia
and intermittent generalized seizures. Intravenous immunoglo-
bulin was added (35 g/d for 2 days) without improvement.
Approximately one month after onset of illness, the patient
died of respiratory failure. 
Postmortem examination of the brain showed multiple
meningiomas, generalized atrophy, and surgical resection of
the right parietal lobe. Histology was remarkable for neu-
rofibrillary plaques consistent with Alzheimer’s disease, and
scattered microglial nodules and perivascular lymphocytic
inflammation in the medulla, pons, and midbrain were consis-
tent with viral encephalitis.
RNA was extracted from frontal cortex and cerebellum
with TRI-Reagent (Molecular Research Center, Cincinnati,
OH). Four micrograms of total RNA from each brain region
were used as a template for reverse transcription-polymerase
chain reaction (RT-PCR) with primer sets representing three
regions of sequence conservation in flavivirus genomes: NS3-
1 (EDL/Fla-U5004, 5´- GGA ACD TCM GGH TCN CCH AT
and EDL/Fla-L5457, 5´- GTG AAR TGD GCY TCR TCC
AT), NS5-1.1 (EDL/Fla-U9093, 5´- AGY MGR GCH ATH
TGG TWY ATG TGG and EDL/Fla-L9279, 5´- TCC CAV
CCD GCK GTR TCA TC), and NS5-2 (EDL/Fla-U9954, 5´-
GSS AAA KCH TAY GCN CAV ATG TGG and EDL/Fla-
L10098 5´- AGC ATR TCT TCH GTN GTC ATC CA)
(15,16). Amplification products were obtained with RNA
derived from the cerebellum in reactions with all three primer
sets; no amplification products were obtained with RNA from
the cortex. These amplification products were cloned into the
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pGEM-Teasy vector (Promega, Madison, WI) and subjected to
automated dideoxy sequencing (ABI Prism Model 377, Foster
City, CA). Sequences were submitted to GenBank (NS3, Gen-
Bank accession no. AF394218; NS5, GenBank accession nos.
AF394219 and AF394220).
Signal of cerebellar amplification products in ethidium
bromide-stained gels was reduced in comparison with similar
studies performed with brain materials from four patients of
the 1999 New York City outbreak (data not shown; New York
patients were 75 years to 80 years of age, 3 male, 1 female,
who died of severe WNV encephalitis during the 1999 out-
break [16]). The 5´-nuclease real-time RT-PCR analysis (17)
indicated a relative virus load of 140 copies/200 ng RNA in
the Israeli sample, compared with a range of 20 to 7000 cop-
ies/200 ng RNA in specimens analyzed from the New York
City outbreak (Table). However, since the virus load of the
sample from Israel was within the range of virus loads
observed with the New York samples, this result for a single
Israeli sample may not indicate a strain difference. Quantita-
tive analysis was restricted to the NS5 target because no signal
was obtained with primer/probe set prNS3 (fwd, 5´- GCa CTG
AGA GGA CTG CCc AT; probe, 5´-6FAM-TAc CAG ACA
TCc GCA GTG cCC AGA-T-TAMRA; rev, 5´- TGg GTG
AGG GTa GCA TGa CA), because of point mutations in WNV-
ISR2000 sequence that prevented efficient hybridization with
the primer and probe oligonucleotides (fwd - 2 mismatches,
probe – 3 mismatches, rev - 3 mismatches; given above in
lower case). Sensitivity was not substantially reduced in assays
with primer/probe set prNS5, which had one mismatch in the
3′ -terminal sequence of the probe oligonucleotide (Table). 
Sequence analysis of the cloned NS3 and NS5 gene frag-
ments indicated similarity to completely sequenced Romanian
and Russian WNV isolates WNV-RO97-50-1996 and WNV-
RUS-VLG4-1999, respectively; thus, to facilitate detailed
phylogenetic analysis, E gene sequence from the Israel human
brain sample was amplified. An E gene sequence of 1,509
nucleotides (GenBank accession number AF394217) was
amplified from total RNA by using GeneChoice UNIPOL
polymerase (PGC Scientific, Gaithersburg, MD) and primers
EDL/E-U1006 (5´- GGA GTG TCT GGA GCA ACA TGG
GT) or EDL/E-U1476 (5´- TCC TGC GGC GCC TTC AT) and
EDL/E-L2244 (5´- CCC CTC CAA CTG ATC CAA AGT CC)
or EDL/E-L2538 (5´- TCC ATC CAA GCC TCC ACA TCA),
respectively. Sequence analysis of this fragment confirmed
data from NS3 and NS5 sequence analyses, indicating a closer
relationship of WNV-ISR-hISR2000 sequence to Romanian
and Russian isolates than to the 1997/98/99 Israeli and the
WNV-NY1999 isolates (Figure).
The extent to which this WNV genotype contributed to
human disease in the 2000 epidemic remains to be determined.
WNV-ISR-hISR2000 may have been carried into Israel by
migrating birds from reservoirs in southeastern Europe or res-
ervoirs in northeastern Africa, where a highly related virus
was isolated in 1998 (WNV-KEN-KN3829-1998) (18). The
2000 Israel isolates in birds (and pigs, strains ISR-00GooMaS
and ISR-00PigC) were different from the previous Israeli iso-
lates (1997/98/99; strains ISR-97Goo1, ISR-98Goo1, ISR-
IS98St1, ISR-99Goo, and ISR-99Gull [Figure]), but similar to
the human isolate. Nonetheless, precedent exists for implicat-
ing more than one genotypic variant in a WNV outbreak.
Table. Real Time reverse transcription-polymerase chain reaction (RT-PCR) analysis of RNA extracts from 2000 Israel West Nile patient speci-
mens using primer set NY1999-NS5
NS5 standard 
NY1999 Armored RNA
Armored RNA 
extract NY1999 specimens
NS5 standard 
ISR2000
ISR2000 specimens
Amounta CT
b Dil.c  Amountd Dil.e Amountd Patient no. CT Amountd Amountf CT Sample CT Amountg
2.5x106 16.4 1:101 4.5x106 1:101 4.4x105 1 29.3 6.9x102 2.5x106 16.5 cereb. 31.1 1.4x102
2.5x105 20.0 1:102 3.4x105 1:102 4.0x104 2 25.6 7.3x103 2.5x105  20.0 cortex 36.4h 1.9x100
2.5x104 23.6 1:103 3.1x104 1:103 4.3x103 3 30.0 4.6x102 2.5x104  23.1
2.5x103 27.2 1:104 3.1x103 1:104 6.0x102 53 4 . 8 2 . 3  x 1 0 1 2.5x103  26.7
2.5x102 31.1 1:105 3.4x102 1:105 9.8x101 2.5x102  30.3
2.5x101 34.9 1:106 3.1x101 1:10 2.1x100 2.5x101  34.1
2.5x100 36.8h 1:107 3.0x100 h 1:107 n.di 2.5x100  37.3 h
0 > 4 5 0000 0 > 4 5
a Plasmid DNA p88-D-21 was quantitated spectrophotometrically, and dilutions containing the indicated copy number of target sequence were added to each polymerase chain reaction 
(PCR) assay.
b CT , Cycle number at which signal crosses threshold.
c Armored RNA West Nile virus (HNY1999) standard (Ambion, Austin, TX) was diluted 1:10, boiled, reverse transcribed, and then diluted to result in amounts per PCR assay equiva-
lent to the indicated dilution of the stock (5 µL).
d Amount calculated based on calibration curve obtained with NS5 Standard NY1999 (column 1).
e Dilutions of Armored RNA West Nile virus (HNY1999) standard (Ambion) were extracted with TRI-Reagent (Molecular Research Center, Cincinnati, OH) and then subjected to RT-
PCR to result in amounts per assay equivalent to the indicated dilution of the stock (5 µL).
f Plasmid DNA pISR-Dfrag-D6 was quantitated spectrophotometrically, and dilutions containing the indicated copy number of target sequence were added to each PCR assay.
g Amount calculated based on calibration curve obtained with NS5 Standard ISR2000 (column 5).
h Poisson effects take place at low template concentration; duplicate assay deviations: 36.2 / 37.4, NY1999; 6.0 x100 / 0, armored RNA; 37.4 / 37.1, ISR2000; and 36.4 / >45, cortex.
i n.d. ,  not determined.DISPATCHES
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During the 1999 outbreak in Volgograd, Russia, two different
genotypes were isolated: WNV-RUS-ASTR986-1999 (similar
to 1997/98/99 Israeli and the WNV-NY1999 isolates, geno-
type lineage I subtype 2a) and WNV-VLG22889/WNV-RUS-
VLG4-1999 (similar to WNV-ISR-hISR2000, subtype 2b
[Figure]) (19). Indeed, even more divergent genotypes were
identified during the 1996-97 WNV outbreak in Romania
(WNV-RO97-50-1996 similar to WNV-ISR-hISR2000, geno-
type lineage I subtype 2b; WNV-RO96-1030-1996 and WNV-
ROM96(0334)-1996, belonging to a different subtype, subtype
1 [Figure]) (20). The fact that no such divergence of genotypes
of WNV isolates was observed during the 1999 New York epi-
demic (Figure) was interpreted as being compatible with a sin-
gle, new introduction of this virus to the Western Hemisphere.
While this manuscript was under review, another group
reported WNV sequences from four patients of the 2000 Israel
outbreak: two isolates most closely related to WNV-R097-50-
1996 and two identical to the WNV-NY1999 isolates (21).
Analysis of additional isolates from the Israel 2000 and other
outbreaks, including isolates obtained in 2000, 2001, and sub-
sequent years in the USA, will be required to establish the
extent to which avian migration and viral mutation contribute
to the epidemiology of WNV-related disease.
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